Bicocca Open Archive

Logo unimib boa
DELL'ORO, RAFFAELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.031
AS - Asia 7.603
EU - Europa 5.865
SA - Sud America 1.161
AF - Africa 131
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 9
Totale 26.821
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.764
SG - Singapore 2.736
CN - Cina 1.846
HK - Hong Kong 1.227
RU - Federazione Russa 1.186
VN - Vietnam 1.036
BR - Brasile 970
IT - Italia 902
DE - Germania 889
SE - Svezia 862
IE - Irlanda 636
UA - Ucraina 395
GB - Regno Unito 304
KR - Corea 183
CA - Canada 182
IN - India 154
FI - Finlandia 146
FR - Francia 131
AT - Austria 120
AR - Argentina 73
ID - Indonesia 70
ZA - Sudafrica 64
NL - Olanda 58
BD - Bangladesh 55
JP - Giappone 54
MX - Messico 53
PL - Polonia 47
TR - Turchia 45
DK - Danimarca 40
IQ - Iraq 40
EC - Ecuador 37
BE - Belgio 27
ES - Italia 22
PK - Pakistan 22
SA - Arabia Saudita 22
AU - Australia 21
CZ - Repubblica Ceca 19
VE - Venezuela 19
CO - Colombia 17
KE - Kenya 16
CL - Cile 15
UZ - Uzbekistan 15
LT - Lituania 13
PY - Paraguay 12
TN - Tunisia 12
AE - Emirati Arabi Uniti 11
MA - Marocco 11
PE - Perù 11
IR - Iran 10
RO - Romania 10
BG - Bulgaria 9
JO - Giordania 9
EE - Estonia 8
LK - Sri Lanka 8
DO - Repubblica Dominicana 7
EU - Europa 7
MY - Malesia 7
CH - Svizzera 6
IL - Israele 6
PH - Filippine 6
AZ - Azerbaigian 5
BH - Bahrain 5
EG - Egitto 5
ET - Etiopia 5
HN - Honduras 5
JM - Giamaica 5
KZ - Kazakistan 5
PA - Panama 5
RS - Serbia 5
UY - Uruguay 5
HR - Croazia 4
PT - Portogallo 4
AL - Albania 3
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
DZ - Algeria 3
GR - Grecia 3
MK - Macedonia 3
MU - Mauritius 3
SN - Senegal 3
BB - Barbados 2
BO - Bolivia 2
CR - Costa Rica 2
HU - Ungheria 2
KG - Kirghizistan 2
KH - Cambogia 2
MG - Madagascar 2
NP - Nepal 2
OM - Oman 2
PS - Palestinian Territory 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BN - Brunei Darussalam 1
Totale 26.804
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.870
Singapore 1.600
Hong Kong 1.218
Ashburn 1.015
Fairfield 898
Woodbridge 884
Houston 625
Dublin 611
Chandler 587
Frankfurt am Main 544
Wilmington 470
Hefei 405
Jacksonville 403
New York 353
Seattle 349
Beijing 307
Dallas 306
Ho Chi Minh City 278
Dearborn 268
Hanoi 268
Milan 263
Santa Clara 242
Cambridge 235
Princeton 210
Los Angeles 203
Seoul 179
Moscow 127
Nanjing 108
Lawrence 104
Chicago 102
Vienna 99
Shanghai 97
Altamura 94
Buffalo 89
São Paulo 89
The Dalles 81
Munich 73
Lachine 63
San Diego 57
Jakarta 52
Guangzhou 49
London 47
Lissone 46
Da Nang 45
Council Bluffs 41
Nanchang 41
Dong Ket 40
Boardman 38
Helsinki 37
Chennai 36
Rio de Janeiro 36
Warsaw 35
Rome 33
Andover 32
Changsha 32
Toronto 32
Turku 32
Düsseldorf 31
Shenyang 31
Tokyo 31
Hebei 30
Montreal 29
Haiphong 28
Tianjin 28
Brooklyn 27
Nuremberg 27
Salt Lake City 27
Atlanta 25
Fremont 25
Johannesburg 25
Columbus 24
Falls Church 24
Belo Horizonte 23
Brussels 22
Zhengzhou 22
Denver 21
Jiaxing 21
Jinan 21
Kunming 21
Phoenix 21
Hangzhou 20
Poplar 20
Ha Long 19
Monza 19
Norwalk 19
Ningbo 18
Ottawa 18
Quận Bình Thạnh 18
San Francisco 18
Kent 17
Orem 17
Baghdad 16
Can Tho 16
Cinisello Balsamo 16
Hải Dương 16
Amsterdam 15
Brasília 15
Sacramento 15
Brno 14
Campinas 14
Totale 17.402
Salva come PNG Salva come JPEG
Nome #
Baroreceptors as a target of device-based neuromodulation in heart failure: Long-term outcomes 423
Contrasting effects of carotid baroreceptor stimulation on regional sympathetic drive in chronic human heart failure 406
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 390
Heart rate as a sympathetic marker during acute adrenergic challenge 377
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 294
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 280
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 269
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 266
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 264
Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea 261
Severe systemic cytomegalovirus infection in an immunocompetent patient outside the intensive care unit: a case report 259
Structural alterations of the retinal microcirculation in the "prehypertensive" high-normal blood pressure state 251
It is never too late for a genetic disease: a case of a 79-year-old man with persistent hypokalemia 251
Patterns of regional sympathetic nerve traffic in preascitic and ascitic cirrhosis 249
Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients 247
Neurogenic abnormalities in masked hypertension 244
Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state 244
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome 242
Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child a cirrhosis 242
Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: Characteristics and mechanisms 238
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies 238
Sympathetic nerve traffic and baroreflex function in optimal, normal, and high-normal blood pressure states 234
Prevalence of cardiovascular risk factors in an unselected Italian population. Results of the CardioLab Project 2004-2008 233
Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years 232
Sustained sympathoinhibitory effects of cardiac resynchronization therapy in severe heart failure 231
IMPACT OF SEASONAL BLOOD PRESSURE CHANGES ON VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY 228
Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives 228
Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease 227
Threshold and Target for Blood Pressure Lowering in the Elderly 226
Role of ambulatory blood pressure monitoring in resistant hypertension 224
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 222
Adrenergic and reflex abnormalities in obesity-related hypertension 218
Reproducibility patterns of plasma norepinephrine and muscle sympathetic nerve traffic in human obesity 218
Structural and functional alterations of subcutaneous small resistance arteries in severe human obesity 218
Extreme dipping: Always means nocturnal hypotension? 218
Sympathetic and reflex alterations in systo-diastolic and systolic hypertension of the elderly 214
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 212
Short- and long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension 211
Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study 211
Long-term Saxagliptin Treatment Improves Endothelial Function but not Pulse Wave Velocity and Intima-Media Thickness in Type 2 Diabetic Patients 210
Effects of hypertension and obesity on the sympathetic activation of heart failure patients 208
Multicentre randomised, double blind, evaluation of nebivolol plus HCTZ and irbesartan plus HCTZ in the treatment of systolic hypertension in the elderly: the NEHIS Study 207
Cardiovascular risk and adrenergic overdrive in the metabolic syndrome 206
Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction 206
Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality 206
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 204
Relationship among morning blood pressure surge, 24-hour blood pressure variability, and cardiovascular outcomes in a white population 204
Diurnal blood pressure variation and sympathetic activity 201
Sympathetic Nerve Traffic and Arterial Baroreflex Function in Apparent Drug-Resistant Hypertension 200
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation 198
Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications 194
Primary and secondary prevention of stroke by antihypertensive treatment in clinical trials 191
Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis 191
Reduced Insulin Sensitivity is Associated with Adrenergic Overdrive Independently on Obesity and Hypertension 187
Early sympathetic activation in the initial clinical stages of chronic renal failure 186
Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension 186
Novel Antihypertensive Therapies: Renal Sympathetic Nerve Ablation and Carotid Baroreceptor Stimulation 184
Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report 184
The "J curve" problem revisited: old and new findings 183
Predictive value of different indices of blood pressure variability on 182
Different neuroadrenergic activation and baroreflex function in resistant and pseudoresistant hypertension: a microneurographic study 179
Effects of acute carotid baroreceptor stimulation on sympathetic nerve traffic in resistant and uncontrolled hypertension: a systematic review and meta-analysis 177
Triglyceride-glucose Index and Mortality in a Large Regional-based Italian Database (Urrah Project) 177
Clinical correlates and subclinical cardiac organ damage in different extreme dipping patterns 172
Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives 170
Sympathetic and baroreflex function in hypertensive or heart failure patients with ventricular arrhythmias 170
Response to sympathetic activity, heart failure, obesity, and metabolic syndrome: Is there any role for obstructive sleep apnea? 169
Sympathetic activation in congestive heart failure: Evidence, consequences and therapeutic implications 169
Pheochromocytoma as a Clinical Model of Peripheral Sympathetic Overdrive: Old and New Findings 169
Sympathetic activation in obesity: a noninnocent bystander 168
SYMPATHETIC OVERDRIVE IN THE RESISTANT HYPERTENSIVE PHENOTYPE 168
Comparison of electrocardiographic versus echocardiographic detection of left ventricular mass changes over time and evaluation of new onset left ventricular hypertrophy 167
How to assess sympathetic nervous system activity in clinical practice 166
Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis 166
Baroreflex activation therapy systems: current status and future prospects 164
Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity 163
Reduced insulin sensitivity is associated with adrenergic overdrive in hemochromatosis independently on obesity and hypertension 163
Antihypertensive treatment and stroke prevention: From recent meta-analyses to the PRoFESS trial 162
Salt intake and sympathetic activity - Response 162
Essential hypertension and the sympathetic nervous system 160
Left ventricular hypertrophy in isolated and dual masked hypertension 159
New onset left atrial dilatation in the general population: A quarter-century follow-up 158
Long-term increase in serum uric acid and its predictors over a 25 year follow-up: Results of the PAMELA study 158
Retinal arteriolar narrowing as marker of renal dysfunction: potential value and limitations 156
High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid 156
COVID-19, hypertension and cardiovascular diseases: Should we change the therapy? 155
Blood pressure control and antihypertensive treatment 154
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 153
Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: Results of the CROSS study 151
Muscle and skin sympathetic nerve traffic during physician and nurse blood pressure measurement 149
The neglected role of the electrocardiogram in the diagnostic work-up of hypertensive patients: a study in clinical practice 148
Association Between Arterial Stiffness, High Blood Pressure, and Hypertensive Phenotypes: Insights from the PAMELA Study 147
Limited reliability of heart rate as a sympathetic marker in chronic kidney disease 147
Long-term changes in left ventricular mass echocardiographic findings from a general population 146
Habitual Regular Coffee Consumption And Arterial Stiffness -Data From The 3rd Pamela Survey 142
Risk of Cardiovascular Events in Metabolically Healthy Overweight or Obese Adults: Role of LDL-Cholesterol in the Stratification of Risk 141
Coffee consumption, clinic, 24-hour and home blood pressure. Findings from the PAMELA study 141
Prevalence, Awareness And Treatment Of Cardiovascular Risk Factors In Health Professionals In The Cardiovascular Field: The Protecto Esh-Siia Study 140
The PAMELA research project: a 25-year long journey 140
Cardio-Ankle Vascular Index As A Marker Of Left Ventricular Hypertrophy In Treated Hypertensives: Findings From The Pamela Study 139
Totale 20.399
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.034
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.034
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.412 0 0 0 0 0 211 240 225 186 242 116 192
2021/20221.700 147 125 235 183 138 128 71 68 95 110 163 237
2022/20232.510 270 708 231 253 150 408 41 155 140 34 80 40
2023/20242.062 51 54 89 112 285 491 388 61 224 39 41 227
2024/20255.787 329 665 231 251 467 161 288 280 536 852 710 1.017
2025/20267.332 1.888 1.086 1.158 1.564 1.445 191 0 0 0 0 0 0
Totale 27.412